200 filings
Page 4 of 10
8-K
5ng 0c6ftmajb2y6osjx
26 Jan 23
Revolutionizing the treatment of Cystic Fibrosis through our unique BOLT Phage therapy platform Investor Presentation / Jan 2023
8:31am
8-K
85dwfz7 7v5ibtc2xvu
6 Jan 23
Departure of Directors or Certain Officers
4:30pm
8-K
doz pjmwnvjyrp
9 Nov 22
BiomX Reports Third Quarter 2022 Financial Results and Provides Business Update
7:25am
8-K
19ghh7wf
29 Aug 22
Submission of Matters to a Vote of Security Holders
4:01pm
8-K
qkuppke ai
10 Aug 22
BiomX Reports Second Quarter 2022 Financial Results and Provides Business Update
12:00am
DEFA14A
po44j2m8cxqziq
7 Jul 22
Additional proxy soliciting materials
4:02pm
8-K
1uz 1qsz4m0
6 Jul 22
Other Events
6:06am
8-K
bkyqkpdt 9xi
27 Jun 22
Other Events
4:05pm
PRE 14A
a32dec6c
21 Jun 22
Preliminary proxy
4:30pm
8-K
v583smt17yf9x6uofslg
14 Jun 22
Shareholder Nominations Pursuant to Exchange Act Rule 14a-11
4:37pm
8-K
99cye6sfli
24 May 22
Other Events
4:05pm
8-K
njkal
11 May 22
BiomX Reports First Quarter 2022 Financial Results and Provides Business Update
7:50am
424B5
il5hrsmrqhifbj 2tmu
8 Apr 22
Prospectus supplement for primary offering
4:05pm
S-8
jrxhyft
30 Mar 22
Registration of securities for employees
5:16pm